Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Long Term Provisions ₹155 Cr₹123 Cr₹98 Cr₹80 Cr₹72 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹155 Cr based on Mar2025 Consolidated results.
Year Long Term Provisions
Mar2025₹155 Cr
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr
Mar2021₹72 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2025 ₹155 Cr
25.94
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr
10.74
Mar2021 ₹72 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹107,171.1 Cr 1.1% -0.2% 11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,451.0 Cr 2.1% 0.3% -9.6% Stock Analytics
DIVIS LABORATORIES ₹161,727.0 Cr -0% 1.1% 13.4% Stock Analytics
CIPLA ₹124,533.0 Cr -1.1% -3.2% -4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,673.0 Cr 3.4% 0.2% 8.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,629.0 Cr -0.7% 2% 0.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-0.2%

11%

SENSEX

0.5%

0.4%

-1.1%


You may also like the below Video Courses